Ltejk8sjrzon6t8yil6u bart

Barts Cancer Institute

2 Orders Completed
London, GB

About Barts Cancer Institute

BCI was created in 2003, and brought together some of the most eminent cancer research teams in London. We are one of the six Institutes within the Barts and The London School of Medicine and Dentistry, Queen Mary University of London.

Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, we have created an academic environment fitting for an internationally recognised, comprehensive cancer centre.

Barts Cancer Institute has a long tradition of pioneering research and innovation. Many surgical procedures were first discovered here as well as the use of radiotherapy to treat cancer.

By investing in and undertaking world-class research, we aim to prevent cancer and develop better diagnostic techniques and treatments. This will ultimately increase patient survival and enhance the quality of life for those with long-term disease.

A wide range of research is currently underway and includes:

  • Therapeutic and diagnostic target identification and validation in both haematological and solid malignancies
  • Clinical trials exploring new therapies
  • The development of novel molecular approaches for diagnosis
  • Classification and treatment of human cancers
  • Investigations into the regulation of tumour spread and host anti-tumour responses

We are recognised as one of the leading Cancer Research Institutions in the UK and are a Cancer Research UK Centre of Excellence - one of only 17 in the country.

Our Services (12)


ic

Targeted Metabolomics

Price on request
Request a quote for more information about this service.

ic

Non-Targeted Metabolomics

Price on request
Request a quote for more information about this service.

ic

Metabolomics

Price on request
Request a quote for more information about this service.

ic

Proteomics

Price on request

The MS facility can provide access to advanced MS, proteomics and metabolomics technologies.
Proteomics

A series of analytical techniques that enable:

  • Protein identification
  • Determination of protein post-translational modifications such as: phosphorylation, acetylation, and more
  • Relative quantification of proteins and their modifications
  • Absolute protein quantification in targeted mode
  • Molecular weight determination of intact proteins (top-down proteomics)


ic

Mass Spectrometry

Price on request

The mass spectrometry (MS) laboratory is a Core Service at Barts Cancer Institute and is currently managed by the Centre for Haemato-Oncology. MS has a variety of applications in cell and molecular biology and cancer research, including the analysis of:

Pharmacokinetics and pharmacodynamics of drugs
Samples' protein composition
Protein structures
Post-translational modifications of proteins
Enzymatic activity

MS is also the preferred analytical method in metabolomics and proteomics.

The MS Laboratory supports BCI researchers through collaborations in a variety of high quality m


ic

Bioinformatics

Price on request

Our Philosophy:

  • Identify barriers preventing data being used to their maximal potential and develop bioinformatics methods to address these.
  • Work closely with basic and clinical scientists to provide the bioinformatics backbone to support cutting edge research and translate data into diagnostics and therapeutics.


ic

Spectroscopy

Price on request
Request a quote for more information about this service.

ic

Omics

Price on request
Request a quote for more information about this service.

ic

Biostatistics & Bioinformatics

Price on request
Request a quote for more information about this service.

ic

Imaging & Spectroscopy

Price on request
Request a quote for more information about this service.

ic

Computational Modeling

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
  • Positive review for Mass Spectrometry:

    November 2017

    "We had a very good experience with Dr. Pedro Cutillas and team at Barts Cancer Institute, they followed our tight timelines and provided very robust data, we recommend this group for phosphoproteomics studies."

Barts Cancer Institute has not received any endorsements.